Perspective: targeting VEGF-A and YKL-40 in glioblastoma – matter matters

Glioblastomas (GBM) are heterogeneous highly vascular brain tumors exploiting the unique microenvironment in the brain to resist treatment and anti-tumor responses. Anti-angiogenic agents, immunotherapy, and targeted therapy have been studied extensively in GBM patients over a number of decades with...

Descripción completa

Detalles Bibliográficos
Autores principales: Holst, Camilla Bjørnbak, Pedersen, Henriette, Obara, Elisabeth Anne Adanma, Vitting-Seerup, Kristoffer, Jensen, Kamilla Ellermann, Skjøth-Rasmussen, Jane, Lund, Eva Løbner, Poulsen, Hans Skovgaard, Johansen, Julia Sidenius, Hamerlik, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078714/
https://www.ncbi.nlm.nih.gov/pubmed/33779510
http://dx.doi.org/10.1080/15384101.2021.1901037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078714/
https://www.ncbi.nlm.nih.gov/pubmed/33779510
http://dx.doi.org/10.1080/15384101.2021.1901037

Ejemplares similares